open access

Vol 14, No 6 (2019)
Case Reports
Published online: 2019-12-31
Get Citation

Atrioventricular junction ablation as a bridging treatment of tachycardiomyopathy and renal insufficiency in the course of atrial fibrillation with high frequency ventricular rhythm

Tomasz Pawlik, Agnieszka Wojdyła-Hordyńska, Grzegorz Hordyński, Marek Gierlotka
DOI: 10.5603/FC.2019.0112
·
Folia Cardiologica 2019;14(6):603-605.

open access

Vol 14, No 6 (2019)
Case Reports
Published online: 2019-12-31

Abstract

We present the case of a 67 year-old woman with tachycardiomyopathy induced by atrial fibrillation with high frequency ventricular response. The patient underwent resynchronisation pacemaker implantation and atrioventricular junction ablation as a bridging therapy prior to cryoballoon pulmonary vein ostia ablation.

Abstract

We present the case of a 67 year-old woman with tachycardiomyopathy induced by atrial fibrillation with high frequency ventricular response. The patient underwent resynchronisation pacemaker implantation and atrioventricular junction ablation as a bridging therapy prior to cryoballoon pulmonary vein ostia ablation.
Get Citation

Keywords

tachycardiomyopathy, atrial fibrillation, junction ablation, bridging therapy

About this article
Title

Atrioventricular junction ablation as a bridging treatment of tachycardiomyopathy and renal insufficiency in the course of atrial fibrillation with high frequency ventricular rhythm

Journal

Folia Cardiologica

Issue

Vol 14, No 6 (2019)

Pages

603-605

Published online

2019-12-31

DOI

10.5603/FC.2019.0112

Bibliographic record

Folia Cardiologica 2019;14(6):603-605.

Keywords

tachycardiomyopathy
atrial fibrillation
junction ablation
bridging therapy

Authors

Tomasz Pawlik
Agnieszka Wojdyła-Hordyńska
Grzegorz Hordyński
Marek Gierlotka

References (6)
  1. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 1993; 16(6): 1275–1284.
  2. Nia AM, Gassanov N, Dahlem KM, et al. Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study. Clin Res Cardiol. 2011; 100(10): 887–896.
  3. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014; 7(1): 31–38.
  4. Khan MN, Jaïs P, Cummings J, et al. PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008; 359(17): 1778–1785.
  5. Di Biase L, Mohanty P, Mohanty S, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016; 133(17): 1637–1644.
  6. Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004; 110(3): 247–252.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl